RAT BASOPHILIC LEUKEMIA (RBL) CELL ACTIVATION
RAT BASOPHILIC LEUKEMIA (RBL) CELL ACTIVATION
批准号:
6298056
负责人:
LARRY A. SKLAR
金额:
$0.36万
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-09-30 至 1999-06-30
中文摘要
细胞活化的途径对过敏和哮喘很重要
正在通过分离RBL(大鼠嗜碱性白血病)细胞进行检查
与甲酰肽受体结合。 这允许信号的比较
由不同的机制启动的转导途径,
类似的细胞反应。 主要途径涉及G蛋白
由甲酰肽和受体激酶启动的介导信号
由IgE受体的交联引发的相关信号,
抗原的 通过流式细胞术对转染细胞进行表征
信号通路和运动反应的几个方面
被评估。 这些包括肌动蛋白聚合、磷酸酪氨酸
激酶活化和钙应答,全部通过流式细胞术。 两
论文已经发表(Hall等人,勒克。 1997; Lee等人
al. BBRC,1997年)
英文摘要
The pathways of cell activation important to allergy and asthma
are being examined by transfecting RBL (rat basophilic leukemia) cells
with formyl peptide receptors. This permits the comparison of signal
transduction pathways initiated by distinct mechanisms but leading to
similar cell response. The primary pathways involve G protein
mediated signals initiated by formyl peptide and receptor kinase
associated signals initiated by crosslinking of the IgE receptor by
antigen. Transfected cells are being characterized by flow cytometry
and several aspects of the signalling pathway and motile response have
been evaluated. These include actin polymerization, phosphotyrosine
kinase activation, and calcium response, all by flow cytometry. Two
paper have been published (Hall et al., J. Leuk. Biol. 1997; Lee et
al. BBRC, 1997)
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Autophagy Scientific Core
-
批准号:10249118
-
项目类别:
-
资助金额:$23.99万
-
财政年份:2017
-
负责人:LARRY A. SKLAR
-
依托单位:
Illuminating the Druggable Genome Resource Dissemination and Outreach Center (IDG-RDOC)
-
批准号:10532379
-
项目类别:
-
资助金额:$50.0万
-
财政年份:2017
-
负责人:LARRY A. SKLAR
-
依托单位:
Illuminating the Druggable Genome Resource Dissemination and Outreach Center (IDG-RDOC)
-
批准号:10314062
-
项目类别:
-
资助金额:$50.0万
-
财政年份:2017
-
负责人:LARRY A. SKLAR
-
依托单位:
NOVEL DNA DOUBLE STRAND BREAK REPAIR TARGETING THERAPEUTICS FOR CANCER TREATMENT
-
批准号:8693254
-
项目类别:
-
资助金额:$46.26万
-
财政年份:2014
-
负责人:LARRY A. SKLAR
-
依托单位:
NOVEL DNA DOUBLE STRAND BREAK REPAIR TARGETING THERAPEUTICS FOR CANCER TREATMENT
-
批准号:8827725
-
项目类别:
-
资助金额:$36.12万
-
财政年份:2014
-
负责人:LARRY A. SKLAR
-
依托单位:
NOVEL DNA DOUBLE STRAND BREAK REPAIR TARGETING THERAPEUTICS FOR CANCER TREATMENT
-
批准号:9187077
-
项目类别:
-
资助金额:$14.56万
-
财政年份:2014
-
负责人:LARRY A. SKLAR
-
依托单位:
University of New Mexico Center for Molecular Discovery
-
批准号:8443190
-
项目类别:
-
资助金额:$58.99万
-
财政年份:2012
-
负责人:LARRY A. SKLAR
-
依托单位:
Administration
-
批准号:8443193
-
项目类别:
-
资助金额:$9.83万
-
财政年份:2012
-
负责人:LARRY A. SKLAR
-
依托单位:
HIGH THROUGHPUT, HIGH CONTENT MOLECULAR LIBRARIES SCREENING
-
批准号:8361764
-
项目类别:
-
资助金额:$2.24万
-
财政年份:2011
-
负责人:LARRY A. SKLAR
-
依托单位:
LIGAND-RECEPTOR SYSTEMS
-
批准号:8361739
-
项目类别:
-
资助金额:$1.12万
-
财政年份:2011
-
负责人:LARRY A. SKLAR
-
依托单位:
Administration
-
批准号:8116588
-
项目类别:
-
资助金额:$162.53万
-
财政年份:2010
-
负责人:LARRY A. SKLAR
-
依托单位:
HIGH THROUGHPUT, HIGH CONTENT MOLECULAR LIBRARIES SCREENING
-
批准号:8169400
-
项目类别:
-
资助金额:$3.34万
-
财政年份:2010
-
负责人:LARRY A. SKLAR
-
依托单位:
LIGAND-RECEPTOR SYSTEMS
-
批准号:8169375
-
项目类别:
-
资助金额:$1.67万
-
财政年份:2010
-
负责人:LARRY A. SKLAR
-
依托单位:
LIGAND-RECEPTOR SYSTEMS
-
批准号:7956755
-
项目类别:
-
资助金额:$1.61万
-
财政年份:2009
-
负责人:LARRY A. SKLAR
-
依托单位:
HIGH THROUGHPUT, HIGH CONTENT MOLECULAR LIBRARIES SCREENING
-
批准号:7956782
-
项目类别:
-
资助金额:$3.22万
-
财政年份:2009
-
负责人:LARRY A. SKLAR
-
依托单位:
LIGAND-RECEPTOR SYSTEMS
-
批准号:7724229
-
项目类别:
-
资助金额:$1.61万
-
财政年份:2008
-
负责人:LARRY A. SKLAR
-
依托单位:
HIGH THROUGHPUT, HIGH CONTENT MOLECULAR LIBRARIES SCREENING
-
批准号:7724258
-
项目类别:
-
资助金额:$3.22万
-
财政年份:2008
-
负责人:LARRY A. SKLAR
-
依托单位:
Administration
-
批准号:8344435
-
项目类别:
-
资助金额:$92.9万
-
财政年份:2008
-
负责人:LARRY A. SKLAR
-
依托单位:
University of New Mexico Center for Molecular Discovery
-
批准号:8116592
-
项目类别:
-
资助金额:$321.76万
-
财政年份:2008
-
负责人:LARRY A. SKLAR
-
依托单位:
University of New Mexico Center for Molecular Discovery
-
批准号:8704042
-
项目类别:
-
资助金额:$80.0万
-
财政年份:2008
-
负责人:LARRY A. SKLAR
-
依托单位:
海外基金